Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF ISIN · CA74319B5027 US Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2020-07-21 Regulatory Filings
Country US United States of America
Listing US PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company that develops and markets incision-free therapies for ablative interventions. The company's primary platform, TULSA-PRO®, combines real-time Magnetic Resonance (MR) imaging with robotically-driven, transurethral thermal ultrasound and closed-loop temperature feedback. This system is designed for the precise and customizable ablation of prostate tissue from the inside-out. It is used to treat various conditions, including localized prostate cancer and benign prostatic hyperplasia (BPH). The technology enables physicians to create customized treatment plans and monitor tissue temperature in real-time, aiming to maximize efficacy while preserving patient quality of life.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It references an attached Exhibit 99.1 titled 'Material Change Report' dated July 21, 2020. The document length is short (1914 characters) and primarily serves as a report filing with an exhibit rather than containing substantive financial data or detailed report content itself. Form 6-K filings are typically used for current reports by foreign private issuers and often fall under general regulatory announcements. Given the short length and nature of the filing, it does not qualify as a full Annual Report (10-K), Interim Report (IR), or other detailed financial reports. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-07-21 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes an exhibit index referencing a press release dated July 21, 2020. The document length is short (1455 characters) and primarily serves as a report submission with an attached press release. There is no substantive financial data or detailed report content within this text. According to the rules, Form 6-K filings are regulatory filings for foreign issuers to report material information. Given the short length and nature of the document, it fits best under Regulatory Filings (RNS).
2020-07-21 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules under the Securities Exchange Act of 1934. Form 6-K is used by foreign private issuers to report material information that is not required to be filed on Forms 20-F or 40-F. The document includes exhibits such as an Underwriting Agreement and consents from law firms, but does not contain financial statements or detailed financial analysis. The document length is 2222 characters, which is relatively short and consistent with a regulatory filing rather than a full report. There is no indication that this is an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is also not a report publication announcement or certification. Therefore, this filing fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2020-07-16 English
SUPPL
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Form F-10, related to a new issue of common shares by Profound Medical Corp. It details the offering price, underwriting agreement, number of shares offered, underwriting fees, and other terms related to the capital raising. The document is focused on the distribution of new shares and the capital raising process, including underwriting details and listing information. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is not an annual report, earnings release, or any other type of report but specifically a financing prospectus supplement.
2020-07-16 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Profound Medical Corp., pursuant to SEC rules. It includes a press release as an exhibit and is signed by the CFO. The document length is short (1358 characters) and primarily serves as a regulatory filing to report current information to the SEC. It does not contain detailed financial statements or comprehensive reports such as annual or quarterly reports. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings like Form 6-K submissions that do not fit other specific categories.
2020-07-16 English
FREE WRITING PROSPECTUS
Capital/Financing Update Classification · 95% confidence The document is titled 'FREE WRITING PROSPECTUS' and is filed pursuant to Rule 433, which is a SEC rule related to prospectus filings for securities offerings. It includes disclaimers about forward-looking statements, references to a registration statement and prospectus filed with the SEC, and details about an offering of common shares. The content is a corporate presentation related to a securities offering, including market data, risk factors, and forward-looking information. This type of document is not a financial report, earnings release, or management discussion, but rather a capital markets document related to fundraising and securities issuance. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the offering, consistent with a capital raising update rather than a simple announcement or regulatory filing.
2020-07-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.